How Did the 2003 Prescription Drug Re-Importation Bill Pass the House?

dc.contributor.author

Adams, Mike

dc.contributor.author

Gokcekus, Omer

dc.contributor.author

Grabowski, Henry G

dc.contributor.author

Tower, Edward

dc.date.accessioned

2010-03-09T15:41:21Z

dc.date.available

2010-03-09T15:41:21Z

dc.date.issued

2006

dc.description.abstract

the major interest groups in the debate over allowing the re-importation of prescription drugs by utilizing a logit model and instrumental variables. Consistent with political support approach, the evidence suggests that Representatives are maximizing their electoral prospects: contributions from pharmaceutical manufacturers shrink the probability of voting for the bill; and Representatives are sensitive to their constituencies - employees of pharmaceutical manufacturing and senior citizens. Representatives' gender and ideology regarding free trade and subsidies are also determining factors. However, the decision was, by and large, a partisan one: party affiliation was the most important factor in passing the bill.

dc.format.extent

144967 bytes

dc.format.mimetype

application/pdf

dc.identifier.uri

https://hdl.handle.net/10161/2013

dc.language.iso

en_US

dc.publisher

SSRN eLibrary

dc.subject

instrumental variables

dc.subject

logit model

dc.subject

prescription drugs

dc.title

How Did the 2003 Prescription Drug Re-Importation Bill Pass the House?

dc.type

Journal article

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Grabowski_how_did_the_prescription_drug.pdf
Size:
141.57 KB
Format:
Adobe Portable Document Format